The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen.
      Google Scholar   
Citation:
Breast Cancer Res. Treat. vol 101 (1) 113-21
Year:
2007
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
Yes
DataSharing:
No
Book Volume:
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
PPP
Sec. Committees:
   
Pharmas:
 
Grants:
CA116201, U-01 GM61373, CA-25224, CA 90628-03, CA87898  
Corr. Author:
 
Authors:
                                     
Primary Study
NCCTG-89-30-52
Secondary Studies:
Phases:
3
Keywords:
Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Hormonal, Breast Neoplasms, Chemotherapy, Adjuvant, Cytochrome P-450 CYP2D6, Cytochrome P-450 CYP2D6 Inhibitors, Female, Genotype, Humans, Kaplan-Meier Estimate, Middle Aged, Neoplasm Recurrence, Local, Proportional Hazards Models, Tamoxifen, Treatment Outcome